You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement
ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In

Vol. 40 No. 11, pp. 666-710, October 1983
PREVIOUS | NEXT
 Content Access
 •Sign in/out
 •Activate online subscription
 •One-time access
 •Individual subscriptions
 •Institutional subscriptions
 •Register for E-mail Alerts
 Display
 •Table of Contents PDF
Advertisement




Table of Contents
Editorial Board
    PDF
Front Matter
    PDF
Back Matter
    PDF
Advertising
    PDF
ARTICLES
Introduction
Robert M. Herndon
Arch Neurol. 1983;40(11):666.
 FULL TEXT PDF
Ad Hoc Working Group on Trials of New Drugs in Multiple Sclerosis
Arch Neurol. 1983;40(11):703.
 FULL TEXT PDF
1. GENERAL PROBLEMS ASSOCIATED WITH CLINICAL TRIALS IN MULTIPLE SCLEROSIS
Attitudes to the Treatment of Multiple Sclerosis
W. I. McDonald
Arch Neurol. 1983;40(11):667-670.
 EXCERPT | FULL TEXT PDF | REFERENCES
Rationales of Current Therapies for Multiple Sclerosis
Byron H. Waksman
Arch Neurol. 1983;40(11):671-672.
 EXCERPT | FULL TEXT PDF
Therapeutic Fads and Quack Care
Stanley van den Noort
Arch Neurol. 1983;40(11):673-674.
 EXCERPT | FULL TEXT PDF
Scoring Techniques and Problems in the Evaluation of Change in Patients
Robert J. Slater
Arch Neurol. 1983;40(11):675-677.
 EXCERPT | FULL TEXT PDF | REFERENCES
Common Problems in Designing Therapeutic Trials in Multiple Sclerosis
William Weiss; James M. Dambrosia
Arch Neurol. 1983;40(11):678-680.
 EXCERPT | FULL TEXT PDF | REFERENCES
2. ANALYSIS OF CLINICAL TRIAL PROTOCOLS RECENTLY USED IN MULTIPLE SCLEROSIS
Systemic Interferon Therapy for Multiple Sclerosis: Design of a Trial
Kenneth P. Johnson
Arch Neurol. 1983;40(11):681-682.
 EXCERPT | FULL TEXT PDF | REFERENCES
Intrathecal Interferon as Treatment of Multiple Sclerosis: A Planned Multicenter Study
Lawrence Jacobs; Judith A. O'Malley; Arnold Freeman; Peter Reese
Arch Neurol. 1983;40(11):683-686.
 EXCERPT | FULL TEXT PDF | REFERENCES
Immunosuppression and Plasmapheresis in Chronic Progressive Multiple Sclerosis: Design of a Clinical Trial
Stephen L. Hauser; David M. Dawson; James R. Lehrich; M. Flint Beal; Sherwin V. Kevy; Howard L. Weiner
Arch Neurol. 1983;40(11):687-690.
 EXCERPT | FULL TEXT PDF | REFERENCES
Plasma Exchange in Acute Multiple Sclerosis: Design of a Cooperative Study
Howard L. Weiner; Peter Dau; Gary Birnbaum; Michael Feldstein; Bhupendra Khatri; Jack Petajan; Michael P. McQuillen
Arch Neurol. 1983;40(11):691-692.
 EXCERPT | FULL TEXT PDF | REFERENCES
Double-blind Trial of Linoleic Acid in Multiple Sclerosis
Donald W. Paty
Arch Neurol. 1983;40(11):693-694.
 EXCERPT | FULL TEXT PDF | REFERENCES
3. PLANNING AND FINANCING OF FUTURE CLINICAL TRIALS IN MULTIPLE SCLEROSIS: WORKSHOPS
Choice of Therapeutic Agents for Trial
Kenneth P. Johnson; George W. Santos
Arch Neurol. 1983;40(11):695-696.
 EXCERPT | FULL TEXT PDF
Financing of Clinical Trials
Stanley van den Noort
Arch Neurol. 1983;40(11):697-699.
 EXCERPT | FULL TEXT PDF
Development of Simple Trial Protocols
Howard L. Weiner; George C. Ebers
Arch Neurol. 1983;40(11):700.
 EXCERPT | FULL TEXT PDF
Patient Selection and Criteria
Donald W. Paty; Floyd A. Davis
Arch Neurol. 1983;40(11):701.
 EXCERPT | FULL TEXT PDF | REFERENCES
Ethical and Legal Aspects of Clinical Trials
Labe C. Scheinberg; Lee S. Goldsmith
Arch Neurol. 1983;40(11):702.
 EXCERPT | FULL TEXT PDF
5. SUGGESTED PROTOCOLS FOR PRELIMINARY AND DEFINITIVE CLINICAL TRIALS IN MULTIPLE SCLEROSIS
A Working Protocol to Be Used as a Guideline for Trials in Multiple Sclerosis
Howard L. Weiner; George W. Ellison
Arch Neurol. 1983;40(11):704-710.
 EXCERPT | FULL TEXT PDF | REFERENCES

HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.